Category: Latest News

Open Briefing Interview with Andrew McLellan

04 March 2019

In this Open Briefing®, Andrew discusses: • Four new OEM proposals under consideration • Growing market enquiries and successful trade shows including ISBER and SLAS • Six months trading results, period ended 31 December 2018 • Changing revenue mix to ongoing consumables sales • Increasing production and delivery under US$11.9m Labcon contract Open Briefing interview…

Discover More >

Bluechiip technology validated in scientific poster at ISBER Symposium Berlin 2019

11 February 2019

The “Pulmonary Biobank Consortium, CIBER of Respiratory Diseases (CIBERES) – ISCIII (Madrid), Institut d’Investigació Sanitària de les Illes Balears (IdISBA) – Hospital Universitari Son Espases, Mallorca, Spanish Biobank Network” recently presented a scientific poster about Bluechiip technology in the International Society of Biobanks and Environmental Repositories (ISBER) Symposium this February 2019 in Berlin. See CIBERES…

Discover More >

Open Briefing interview with MD Andrew McLellan – Jan 2019

30 January 2019

In this Open Briefing, Andrew discusses: Labcon’s official release and marketing of Bluechiip enabled product Accelerating sales and production scaling progress Reader production status and approvals Partner progress and cash position Download the full document here:

Discover More >

AGM presentation

17 December 2018

Download the presentation shown during the past AGM on the 26th of November 2018

Discover More >

Open Briefing interview with MD Andrew McLellan – 18/10/2018

19 October 2018

In this Open Briefing, Andrew discusses: Recent #7.5M capital raise and the updated $15.9M over 3 yr Labcon agreement Recent customer activity and finalisation and product portfolio Recent 4C and cashflow forecast Partner and opportunity pipeline Read the full announcement here:

Discover More >

Bluechiip Raises $5.5M and announces share purchase plan

11 September 2018

Download the full announcement here:   BLUECHIIP RAISES $5.5 MILLION AND ANNOUNCES SHARE PURCHASE PLAN   Bluechiip Limited (Bluechiip or the Company, ASX: BCT), a leader in the development of sample-tracking technology for harsh environments, today announced it has successfully raised $5.5 million via an oversubscribed placement to sophisticated and professional investors. The placement comprised…

Discover More >

Open Briefing interview with MD Andrew McLellan

01 September 2018

Download the ASX announcement here:   In this Open Briefing®, Andrew discusses: ·                     A$15.9m, three-year deal with Labcon North America ·                     Expectation for margins and NPAT and operating cash flow positive from this one contract ·                     Ramp up of production and consideration of working capital sources ·                     Adjacent markets beyond this Labcon order that can…

Discover More >